Inventor · disambiguated record
Kou-Ichi Jishage
Also filed as: JISHAGE KOU-ICHI
7 granted patents·6 pending applications·56 citations·filing 2000–2010
81Inventor score
Top patents by PatentIndex Score
13 records- 0190US6791006B2LKB1 gene knockout miceCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Granted Sep 14, 2004·32 cites·3 claims
- 0287US7750204B2Methods for producing antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Granted Jul 6, 2010·19 cites·2 claims
- 0375US8013208B2Methods for producing antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Granted Sep 6, 2011·1 cites·43 claims
- 0467US6982362B1α-tocopherol transport protein knockout animalINOUE KEIZO·Filed 2000·Granted Jan 3, 2006·4 cites·7 claims
- 0557US2005044584A1LKB1 gene knockout animalsCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Application pending·0 cites
- 0656US8067665B2Methods of using human tissue factor-producing knock-in miceHABU KIYOSHI·Filed 2009·Granted Nov 29, 2011·0 cites·3 claims
- 0756US2009092995A1Method for Identifying Within a Mammal a DNA encoding a Physiologically Active PolypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2008·Application pending·0 cites
- 0855US2010329988A1Method for Identifying Within a Mammal a DNA Encoding A Physiologically Active PolypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Application pending·0 cites
- 0952US7964767B2Transgenic mice expressing baculovirus soluble GP64 and methods of using such mice to make antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted Jun 21, 2011·0 cites·14 claims
- 1047US7592502B2Knock-in non-human animal producing human tissue factorCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Sep 22, 2009·0 cites·3 claims
- 1145US2003171323A1Preventives/remedies for granulomaFiled 2001·Application pending·0 cites
- 1245US2004067509A1Method of identifying dna encoding physiologically active polypeptide in mammalian bodyFiled 2001·Application pending·0 cites
- 1338US2006174354A1Hcv gene transgenic animalKOHARA MICHINORI·Filed 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →